A recent report suggests that inactivation of both FHIT and p53 may have possible synergistic effect resulting in deregulation of proliferation related genes in lung cancer cell lines and tumors [30], particularly in squamous cell carcinoma subtype of non-small cell lung cancer [31]. The gene discussed is FHIT; the disease is non-small cell lung carcinoma.